Deglutition Disorders
Welcome,         Profile    Billing    Logout  
 40 Companies   26 Products   26 Products   26 Mechanisms of Action   1 Trial   852 News 


«12345678910111213...1718»
  • ||||||||||  Dexilant (dexlansoprazole) / Takeda
    Enrollment change, Trial withdrawal:  Evaluating Treatment Response in Laryngo-Pharyngeal Reflux (clinicaltrials.gov) -  Jul 5, 2017   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: Jun 2017 --> Jul 2016 N=20 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Trial completion:  Study of Tongue Pressures (clinicaltrials.gov) -  Jun 30, 2017   
    P=N/A,  N=160, Completed, 
    Recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Enrollment closed:  Botulinum Toxin Injection in Hypercontractile Esophagus (clinicaltrials.gov) -  May 31, 2017   
    P2,  N=24, Active, not recruiting, 
    Recruiting --> Terminated; change in the business strategy of the sponsor Recruiting --> Active, not recruiting
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Demographics and Findings of Upper Endoscopy Patients (clinicaltrials.gov) -  May 30, 2017   
    P=N/A,  N=1177, Terminated, 
    Recruiting --> Active, not recruiting N=3000 --> 1177 | Recruiting --> Terminated | Trial primary completion date: Sep 2018 --> May 2017; Recruitment not being met
  • ||||||||||  Derazol DDR (dexrabeprazole) / Neutec
    Trial primary completion date:  The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity (clinicaltrials.gov) -  May 25, 2017   
    P4,  N=12, Recruiting, 
    Phase classification: P1/2 --> P=N/A | N=100 --> 52 Trial primary completion date: Mar 2017 --> Jun 2017
  • ||||||||||  Enrollment closed:  POEM Anterior Versus Posterior Approach (clinicaltrials.gov) -  May 23, 2017   
    P=N/A,  N=160, Active, not recruiting, 
    Trial primary completion date: Mar 2017 --> Jun 2017 Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion, Cytology:  Esophageal Cytology With FISH in Detecting Esophageal Cancer (clinicaltrials.gov) -  May 11, 2017   
    P=N/A,  N=50, Completed, 
    Recruiting --> Completed | N=100 --> 120 | Initiation date: Jan 2011 --> Apr 2011 | Trial primary completion date: Feb 2017 --> Jan 2015 Terminated --> Completed
  • ||||||||||  Trial initiation date:  Effect of Different Viscous Foods and Liquids on Swallowing Sounds (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=38, Not yet recruiting, 
    Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A Initiation date: Jan 2017 --> Jun 2017
  • ||||||||||  Victoza (liraglutide) / Novo Nordisk, Lyxumia (lixisenatide) / Zealand Pharma, Sanofi
    Trial primary completion date:  Effects of Victoza (clinicaltrials.gov) -  May 3, 2017   
    P1,  N=72, Active, not recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Apr 2017 --> Jul 2017
  • ||||||||||  Trial primary completion date:  Recurrent Respiratory Papillomatosis and Extraesophageal Reflux (clinicaltrials.gov) -  May 3, 2017   
    P=N/A,  N=60, Recruiting, 
    Recruiting --> Completed | N=54 --> 12 Trial primary completion date: Mar 2017 --> Mar 2018
  • ||||||||||  Trial completion, Phase classification, Enrollment change, Trial primary completion date:  Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Esophageal Motility Disorders (clinicaltrials.gov) -  May 1, 2017   
    P=N/A,  N=50, Completed, 
    Trial primary completion date: Mar 2017 --> Mar 2018 Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=20 --> 50 | Trial primary completion date: Dec 2015 --> Apr 2017
  • ||||||||||  Enrollment change:  Assessment of Esophageal Epithelium Integrity With Mucosal Impedance (clinicaltrials.gov) -  May 1, 2017   
    P=N/A,  N=15, Completed, 
    Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=20 --> 50 | Trial primary completion date: Dec 2015 --> Apr 2017 N=40 --> 15
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Sleep Position May Reduce Acid Reflux Symptoms at Night (clinicaltrials.gov) -  May 1, 2017   
    P=N/A,  N=10, Terminated, 
    N=40 --> 15 N=20 --> 10 | Enrolling by invitation --> Terminated | Trial primary completion date: Sep 2017 --> Mar 2017; low recruitment
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Swallowing and Breathing Exercises for Dysphagia in Parkinson Disease (clinicaltrials.gov) -  Apr 27, 2017   
    P=N/A,  N=38, Completed, 
    N=20 --> 10 | Enrolling by invitation --> Terminated | Trial primary completion date: Sep 2017 --> Mar 2017; low recruitment Recruiting --> Completed | N=100 --> 38 | Trial primary completion date: Apr 2016 --> Dec 2016
  • ||||||||||  esomeprazole / Generic mfg.
    Trial primary completion date:  BRAVO Study for Functional Dyspepsia (clinicaltrials.gov) -  Apr 21, 2017   
    P4,  N=130, Recruiting, 
    Trial primary completion date: Mar 2017 --> Sep 2017 Trial primary completion date: Dec 2015 --> Dec 2017
  • ||||||||||  Enrollment change, Trial termination, Surgery:  STAR Registry: Registry to Compare Two Surgical Treatments for GERD (clinicaltrials.gov) -  Apr 20, 2017   
    P=N/A,  N=46, Terminated, 
    Trial primary completion date: Dec 2015 --> Dec 2017 N=500 --> 46 | Recruiting --> Terminated; Unexpected low accrual
  • ||||||||||  Phase classification:  NewBreez Safety and Efficacy Evaluation (clinicaltrials.gov) -  Apr 11, 2017   
    P=N/A,  N=2, Terminated, 
    Active, not recruiting --> Completed Phase classification: P2/3 --> P=N/A
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Correlation of High Resolution Esophageal Manometry With Symptoms (clinicaltrials.gov) -  Apr 10, 2017   
    P=N/A,  N=0, Withdrawn, 
    Phase classification: P2/3 --> P=N/A N=300 --> 0 | Terminated --> Withdrawn | Trial primary completion date: Feb 2013 --> Aug 2011
  • ||||||||||  Phase classification, Enrollment change:  Feasibility of Placing Bravo PH Capsule in Proximal Esophagus (clinicaltrials.gov) -  Apr 4, 2017   
    P=N/A,  N=39, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2014 Phase classification: P3 --> P=N/A | N=25 --> 39
  • ||||||||||  Enrollment change, Trial primary completion date:  Cough According to Stimulus Type in PD (clinicaltrials.gov) -  Mar 27, 2017   
    P1,  N=220, Recruiting, 
    N=160 --> 0 | Not yet recruiting --> Withdrawn N=150 --> 220 | Trial primary completion date: Mar 2017 --> Mar 2018
  • ||||||||||  Trial completion, Trial primary completion date:  Assessment of Esophageal Epithelium Integrity With Mucosal Impedance (clinicaltrials.gov) -  Mar 14, 2017   
    P=N/A,  N=40, Completed, 
    Trial completion date: Aug 2005 --> Feb 2008 | Recruiting --> Terminated; Project canceled due to the implementation of IMRT, fewer patients reporting xerostomia. Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Dec 2016